The pharmacokinetics and the pharmacodynamics of cannabinoids

British Journal of Clinical Pharmacology
Catherine J LucasJennifer Schneider

Abstract

There is increasing interest in the use of cannabinoids for disease and symptom management, but limited information available regarding their pharmacokinetics and pharmacodynamics to guide prescribers. Cannabis medicines contain a wide variety of chemical compounds, including the cannabinoids delta-9-tetrahydrocannabinol (THC), which is psychoactive, and the nonpsychoactive cannabidiol (CBD). Cannabis use is associated with both pathological and behavioural toxicity and, accordingly, is contraindicated in the context of significant psychiatric, cardiovascular, renal or hepatic illness. The pharmacokinetics of cannabinoids and the effects observed depend on the formulation and route of administration, which should be tailored to individual patient requirements. As both THC and CBD are hepatically metabolized, the potential exists for pharmacokinetic drug interactions via inhibition or induction of enzymes or transporters. An important example is the CBD-mediated inhibition of clobazam metabolism. Pharmacodynamic interactions may occur if cannabis is administered with other central nervous system depressant drugs, and cardiac toxicity may occur via additive hypertension and tachycardia with sympathomimetic agents. More vulnerable...Continue Reading

Associated Clinical Trials

Aug 26, 2020·Timothy A Deimling

References

Mar 1, 1977·Clinical Pharmacology and Therapeutics·N L Benowitz, R T Jones
Nov 1, 1991·Pharmacology, Biochemistry, and Behavior·P ConsroeK Schram
Jan 1, 1989·European Journal of Clinical Pharmacology·E JohanssonH K Gillespie
May 1, 1989·Acta Psychiatrica Scandinavica·S AndréassonU Rydberg
Dec 1, 1987·Pharmacology, Biochemistry, and Behavior·R W FoltinG D Pearlson
Feb 1, 1986·Biomedical & Environmental Mass Spectrometry·A OhlssonL E Hollister
Sep 23, 1982·The New England Journal of Medicine·M Perez-Reyes, M E Wall
Feb 1, 1983·The American Journal of Psychiatry·R B Lacoursiere, R Swatek
Mar 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·J Mackie, D Clark
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·A J HampsonD Wink
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·A M MalfaitM Feldmann
Jul 9, 2002·International Journal of Pharmaceutics·Prasad V N Challapalli, Audra L Stinchcomb
Dec 20, 2002·Psychopharmacology·Ethan B Russo, John M McPartland
Mar 22, 2003·Clinical Pharmacokinetics·Franjo Grotenhermen
Oct 2, 2003·JAMA : the Journal of the American Medical Association·Matthias KarstUdo Schneider
Dec 4, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·M LodzkiE Touitou
Mar 18, 2004·The Journal of Pharmacy and Pharmacology·Audra L StinchcombDiana R Ramsey
Apr 7, 2004·Journal of Pharmaceutical Sciences·Satyanarayana ValivetiAudra L Stinchcomb
Jun 3, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Deepak Cyril D'SouzaJohn Harrison Krystal
Jan 28, 2006·The Journal of Pharmacology and Experimental Therapeutics·Hao-Jie ZhuC Lindsay Devane
Nov 16, 2006·Annals of the New York Academy of Sciences·Emmanuel S OnaiviGeorge R Uhl
Jun 21, 2007·Journal of Analytical Toxicology·Gerold F KauertStefan W Toennes
Aug 23, 2007·Chemistry & Biodiversity·Marilyn A Huestis
Sep 25, 2007·American Journal of Therapeutics·Bill H McCarberg, Robert L Barkin
Mar 13, 2008·Journal of Analytical Toxicology·Gisela Skopp, Lucia Pötsch
May 15, 2009·Clinical Pharmacology and Therapeutics·G J DumontR J Verkes
May 16, 2009·Pain·Tarja HeiskanenEija Kalso
Feb 4, 2011·Clinical Pharmacology and Therapeutics·E L KarschnerM A Huestis
Dec 12, 2012·Clinical Chemistry·Rebecca L Hartman, Marilyn A Huestis
Jan 16, 2013·Drug Metabolism and Pharmacokinetics·Rongrong JiangKazuhito Watanabe
Feb 12, 2013·Lancet·Andrew CleggKenneth Rockwood
Aug 29, 2013·Therapeutic Advances in Psychopharmacology·Zerrin Atakan
Jan 1, 2012·Pharmaceuticals·Simon Zhornitsky, Stéphane Potvin
Feb 11, 2014·Ageing Research Reviews·G A H van den ElsenM G M Olde Rikkert

❮ Previous
Next ❯

Citations

Aug 24, 2018·British Journal of Clinical Pharmacology·Jennifer H Martin, Noel Cranswick
Apr 14, 2019·British Journal of Clinical Pharmacology·Jennifer H Martin, Nicholas J Talley
Jul 20, 2019·Journal of Pharmacy Practice·Amy Hsu, Nathan A Painter
Mar 6, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yuli QianJohn S Markowitz
Oct 29, 2019·British Journal of Clinical Pharmacology·Kirsten Riber BergmannGeert Jan Groeneveld
Dec 14, 2019·Nature Reviews. Neurology·Luigia CristinoVincenzo Di Marzo
Jan 7, 2020·Annual Review of Food Science and Technology·David Julian McClements
Apr 28, 2020·Expert Opinion on Drug Discovery·Paula Morales, Nadine Jagerovic
Oct 9, 2019·International Journal of Environmental Research and Public Health·Jürgen RehmBundit Sornpaisarn
Jun 5, 2019·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Tim RascheMartin Mücke
Apr 8, 2020·European Journal of Drug Metabolism and Pharmacokinetics·Janthima MethaneethornManupat Lohitnavy
Feb 26, 2020·Neurosurgery·Teddy E KimWesley Hsu
Aug 8, 2020·ChemMedChem·Samuele Maramai, Margherita Brindisi
Nov 9, 2019·Journal of Clinical Medicine·Aleksandra Nitecka-BuchtaStefan Baron
Dec 13, 2019·Perioperative Medicine·Patrick Tapley, Suzanne Kellett
Dec 20, 2018·Pharmacy : Journal of Pharmacy, Education and Practice·Allison Karst
Jan 3, 2020·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Anna-Maria SmolyakovaRobert B Laprairie
Apr 14, 2020·Pharmacoepidemiology and Drug Safety·Myfanwy GrahamWayne Hall
May 21, 2020·Medicina·Pietro BrunettiAlessandro Del Rio
Nov 7, 2019·Journal of Clinical Medicine·Ran AbuhasiraVictor Novack
Nov 30, 2019·International Journal of Molecular Sciences·Brigitta KisCorina Danciu
Nov 15, 2019·Journal of Clinical Pharmacology·Jessica GregerFran Gengo
Sep 29, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Gioacchino CalapaiFabio Firenzuoli
Apr 9, 2020·European Journal of Drug Metabolism and Pharmacokinetics·Janthima MethaneethornManupat Lohitnavy
Apr 30, 2020·The Journal of Pharmacology and Experimental Therapeutics·Alexa TorrensDaniele Piomelli
Sep 6, 2019·Journal of the National Comprehensive Cancer Network : JNCCN·Young D ChangDiane Portman
Aug 28, 2020·Expert Opinion on Drug Metabolism & Toxicology·Nuti DesaiTheodore J Cory
Oct 20, 2020·The Annals of Pharmacotherapy·Lindsey Sawtelle, Lisa M Holle
Nov 21, 2020·Internal Medicine Journal·Alistair W Vickery, Phillip M Finch
Oct 21, 2020·Pharmacotherapy·Sarah D Pennypacker, E Alfonso Romero-Sandoval
Dec 18, 2020·Frontiers in Neurology·Paola PerinCinzia Boselli
Dec 19, 2020·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Inna KurlyandchikJanet Schloss
Aug 18, 2020·Journal of Pain and Symptom Management·David CollisterMichael Walsh
Nov 12, 2020·Forensic Science International : Synergy·Enrico GeraceMarco Vincenti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

© 2022 Meta ULC. All rights reserved